W-Ludo van der Pol - JoVE Visualize

Showing results (101-110 of 171) with videos related to

Pageof 18

Sort By:

Journal of the Peripheral Nervous System : JPNS|March 26, 2024

A 21-bp deletion in the complement regulator CD55 promotor region is associated with multifocal motor neuropathy and its disease courseJeroen W Bos, Ewout J N Groen, Henny G Otten, et al.

NMR in Biomedicine|January 20, 2022

Multi-parametric quantitative magnetic resonance imaging of the upper arm muscles of patients with spinal muscular atrophyMelissa T Hooijmans, Laura E Habets, Sandra A M van den Berg-Faay, et al.

Human Molecular Genetics|October 11, 2017

Metalloprotease-mediated cleavage of PlexinD1 and its sequestration to actin rods in the motoneuron disease spinal muscular atrophy (SMA)Sebastian Rademacher, Bert M Verheijen, Niko Hensel, et al.

Chronic Respiratory Disease|April 20, 2022

Short-term effect of air stacking and mechanical insufflation-exsufflation on lung function in patients with neuromuscular diseasesEsther S Veldhoen, Femke Vercoelen, Leandra Ros, et al.

Journal of Neuroimmunology|December 13, 2006

Ganglioside-specific IgG and IgA recruit leukocyte effector functions in Guillain-Barré syndromeNina M van Sorge, Nobuhiro Yuki, Michiaki Koga, et al.

Molecular Genetics & Genomic Medicine|April 2, 2014

Nemaline myopathy caused byTNNT1 mutations in a Dutch pedigreeW Ludo van der Pol, Jolien F Leijenaar, Wim G M Spliet, et al.

Neurology|December 9, 2016

Diagnostic value of sonography in treatment-naive chronic inflammatory neuropathiesH Stephan Goedee, W Ludo van der Pol, Jan-Thies H van Asseldonk, et al.

Neuromuscular Disorders : NMD|November 28, 2020

Long-term follow-up of patients with type 2 and non-ambulant type 3 spinal muscular atrophy (SMA) treated with olesoxime in the OLEOS trialFrancesco Muntoni, Enrico Bertini, Giacomo Comi, et al.

Journal of Neurology, Neurosurgery, and Psychiatry|June 17, 2010

Quantification of SMN protein in leucocytes from spinal muscular atrophy patients: effects of treatment with valproic acidSanne Piepers, Jan-Maarten Cobben, Peter Sodaar, et al.

Annals of Neurology|May 1, 2016

Autoantibody pathogenicity in a multifocal motor neuropathy induced pluripotent stem cell-derived modelOliver Harschnitz, Leonard H van den Berg, Lill Eva Johansen, et al.

Pageof 18

Showing results (101-110 of 171) with videos related to

Sort By:

Pageof 18

Journal of the Peripheral Nervous System : JPNS|March 26, 2024

A 21-bp deletion in the complement regulator CD55 promotor region is associated with multifocal motor neuropathy and its disease courseJeroen W Bos, Ewout J N Groen, Henny G Otten, et al.

NMR in Biomedicine|January 20, 2022

Multi-parametric quantitative magnetic resonance imaging of the upper arm muscles of patients with spinal muscular atrophyMelissa T Hooijmans, Laura E Habets, Sandra A M van den Berg-Faay, et al.

Human Molecular Genetics|October 11, 2017

Metalloprotease-mediated cleavage of PlexinD1 and its sequestration to actin rods in the motoneuron disease spinal muscular atrophy (SMA)Sebastian Rademacher, Bert M Verheijen, Niko Hensel, et al.

Chronic Respiratory Disease|April 20, 2022

Short-term effect of air stacking and mechanical insufflation-exsufflation on lung function in patients with neuromuscular diseasesEsther S Veldhoen, Femke Vercoelen, Leandra Ros, et al.

Journal of Neuroimmunology|December 13, 2006

Ganglioside-specific IgG and IgA recruit leukocyte effector functions in Guillain-Barré syndromeNina M van Sorge, Nobuhiro Yuki, Michiaki Koga, et al.

Molecular Genetics & Genomic Medicine|April 2, 2014

Nemaline myopathy caused byTNNT1 mutations in a Dutch pedigreeW Ludo van der Pol, Jolien F Leijenaar, Wim G M Spliet, et al.

Neurology|December 9, 2016

Diagnostic value of sonography in treatment-naive chronic inflammatory neuropathiesH Stephan Goedee, W Ludo van der Pol, Jan-Thies H van Asseldonk, et al.

Neuromuscular Disorders : NMD|November 28, 2020

Long-term follow-up of patients with type 2 and non-ambulant type 3 spinal muscular atrophy (SMA) treated with olesoxime in the OLEOS trialFrancesco Muntoni, Enrico Bertini, Giacomo Comi, et al.

Journal of Neurology, Neurosurgery, and Psychiatry|June 17, 2010

Quantification of SMN protein in leucocytes from spinal muscular atrophy patients: effects of treatment with valproic acidSanne Piepers, Jan-Maarten Cobben, Peter Sodaar, et al.

Annals of Neurology|May 1, 2016

Autoantibody pathogenicity in a multifocal motor neuropathy induced pluripotent stem cell-derived modelOliver Harschnitz, Leonard H van den Berg, Lill Eva Johansen, et al.

Pageof 18